XML 29 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2023
Apr. 30, 2022
Current Assets    
Cash and cash equivalents $ 8,078 $ 4,433
Restricted cash 5,737 2,461
Receivables, less allowance: $476 (2023); $357 (2022) 46,081 41,254
Inventories 21,889 23,796
Note receivable 0 13,457
Prepaid expenses and other current assets 6,135 6,164
Total Current Assets 87,920 91,565
Property, plant and equipment, net 16,402 15,121
Right of use assets 9,170 7,573
Other assets 5,406 4,514
Total Assets 118,898 118,773
Current Liabilities    
Short-term borrowings 3,587 1,588
Current portion of financing liability 642 575
Current portion of financing lease liabilities 85 126
Current portion of operating lease liabilities 1,967 1,319
Accounts payable 23,599 27,316
Employee compensation and amounts withheld 4,304 4,504
Deferred revenue 4,097 3,529
Other accrued expenses 1,772 3,336
Total Current Liabilities 40,053 42,293
Long-term portion of financing liability 28,132 28,775
Long-term portion of financing lease liabilities 148 228
Long-term portion of operating lease liabilities 7,136 6,179
Accrued pension and deferred compensation costs 3,546 4,159
Deferred income taxes 943 428
Other non-current liabilities 455 531
Total Liabilities 80,413 82,593
Commitments and Contingencies (Note 9)
Stockholders' Equity    
Common stock 7,084 6,983
Additional paid-in capital 5,059 4,483
Retained earnings 28,761 28,023
Accumulated other comprehensive loss (3,442) (3,742)
Common stock in treasury, at cost: 3 shares (53) (53)
Total Kewaunee Scientific Corporation Stockholders' Equity 37,409 35,694
Non-controlling interest 1,076 486
Total Stockholders' Equity 38,485 36,180
Total Liabilities and Stockholders' Equity $ 118,898 $ 118,773